These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32847744)

  • 1. Reply to 'Delirium, sleep, COVID-19 and melatonin'.
    D'Agostino A; Zambrelli E
    Sleep Med; 2020 Nov; 75():543. PubMed ID: 32847744
    [No Abstract]   [Full Text] [Related]  

  • 2. Delirium, sleep, COVID-19 and melatonin.
    Wiwanitkit V
    Sleep Med; 2020 Nov; 75():542. PubMed ID: 32507360
    [No Abstract]   [Full Text] [Related]  

  • 3. Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients?
    Zambrelli E; Canevini M; Gambini O; D'Agostino A
    Sleep Med; 2020 Jun; 70():111. PubMed ID: 32361215
    [No Abstract]   [Full Text] [Related]  

  • 4. Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
    Simko F; Reiter RJ
    Life Sci; 2020 Sep; 256():117902. PubMed ID: 32504754
    [No Abstract]   [Full Text] [Related]  

  • 5. Delirium: a missing piece in the COVID-19 pandemic puzzle.
    O'Hanlon S; Inouye SK
    Age Ageing; 2020 Jul; 49(4):497-498. PubMed ID: 32374367
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence COVID-19: Melatonin as a potential adjuvant treatment.
    Salles C
    Life Sci; 2020 Jul; 253():117716. PubMed ID: 32334009
    [No Abstract]   [Full Text] [Related]  

  • 7. Melatonin as a putative protection against myocardial injury in COVID-19 infection.
    Simko F; Hrenak J; Dominguez-Rodriguez A; Reiter RJ
    Expert Rev Clin Pharmacol; 2020 Sep; 13(9):921-924. PubMed ID: 32893686
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenia and COVID-19 delirium.
    Palomar-Ciria N; Blanco Del Valle P; Hernández-Las Heras MÁ; Martínez-Gallardo R
    Psychiatry Res; 2020 Aug; 290():113137. PubMed ID: 32485483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic?
    Kotfis K; Williams Roberson S; Wilson J; Pun B; Ely EW; Jeżowska I; Jezierska M; Dabrowski W
    Anaesthesiol Intensive Ther; 2020; 52(2):132-138. PubMed ID: 32419438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19.
    Baller EB; Hogan CS; Fusunyan MA; Ivkovic A; Luccarelli JW; Madva E; Nisavic M; Praschan N; Quijije NV; Beach SR; Smith FA
    Psychosomatics; 2020; 61(6):585-596. PubMed ID: 32828569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatments for COVID-19: emerging drugs against the coronavirus - reply.
    Potì F
    Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Neerland BE; Watne LO; Krogseth M
    Tidsskr Nor Laegeforen; 2020 Apr; 140():. PubMed ID: 32323958
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends.
    Kannan S; Shaik Syed Ali Pakeer P; Sheeza Ali A; Hemalatha K
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6482-6483. PubMed ID: 32633333
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 Delirium with Psychosis: A Case Report.
    Losee S; Hanson H
    S D Med; 2020 Aug; 73(8):346-349. PubMed ID: 32809292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authors' Reply to: Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis".
    Mavian C; Marini S; Prosperi M; Salemi M
    JMIR Public Health Surveill; 2020 Nov; 6(4):e24661. PubMed ID: 33174844
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".
    Ather A; Patel B; Ruparel NB; Diogenes A; Hargreaves KM
    J Endod; 2020 Sep; 46(9):1342. PubMed ID: 32810475
    [No Abstract]   [Full Text] [Related]  

  • 17. In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".
    Scullen T; Mathkour M; Keen JR
    World Neurosurg; 2020 Oct; 142():535-536. PubMed ID: 32585382
    [No Abstract]   [Full Text] [Related]  

  • 18. REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.
    Piaserico S; Meneguzzo A; Messina F
    J Infect; 2020 Sep; 81(3):e37-e38. PubMed ID: 32610110
    [No Abstract]   [Full Text] [Related]  

  • 19. In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'.
    De Vriese AS; Reynders M
    Am J Kidney Dis; 2020 Oct; 76(4):598-599. PubMed ID: 32603712
    [No Abstract]   [Full Text] [Related]  

  • 20. Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation.
    Mack AH; Schofield HL
    Psychosomatics; 2020; 61(6):859-860. PubMed ID: 32739050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.